France takes stake in Sanofi
Sanofi is now in “exclusive negotiations” with U.S. private equity firm Clayton, Dubilier & Rice (CD&R) to sell a 50% ...
Yen on MSN21h
Sanofi pursues sale of France's leading painkiller to US investment fund after controversyFrench pharmaceutical company Sanofi confirmed on Monday its plans to sell a controlling stake in its consumer health ...
1d
The proposed sale turned into a real political issue because Opella's products include Doliprane, the best-selling medicine ...
Under the trilateral deal signed by Sanofi, CD&R and the government, Opella will have to pay a €40 million penalty if it ...
Sanofi, which is joining a growing number of drugmakers shedding consumer related businesses, said Opella had been valued at ...
The sale of a French drugmaker to an American group is likely to now go ahead after French Economy Minister Antoine Armand ...
GlobalData on MSN13h
Sanofi’s $17bn sale of Opella to US investors advances following government dealA stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...
Sanofi (SNYNF) announced it has entered into exclusive negotiations to sell a 50 percent controlling stake in its consumer healthcare ...
Together, CD&R and Sanofi will support Opella’s growth strategy as a pure-play, global and fast-moving consumer healthcare company, Sanofi said. Bpifrance is expected to participate as a minority ...
French drugmaker Sanofi's confirmation that it will sell a controlling stake in its consumer health unit Opella to a US ...
France will take a stake in Sanofi’s Opella through the Public Investment Bank, or BPI, finance minister Antoine Armand said on Sunday, confirming an information from Le Figaro ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback